SEARCH BUTTON
HOME > SOLUTIONS > Chemical analysis under Good Manufacturing Practices (GMP)

Chemical analysis under Good Manufacturing Practices (GMP)

At IQS we offer the pharmaceutical industry a quality control physicochemical testing service under the regulatory framework of GMP.

OUR VAST EXPERIENCE IN THE FIELD OF PHYSICOCHEMICAL ANALYSIS IS OUR SEAL OF EXCELLENCE

In response to the needs of the biosanitary sector, IQS offers different physicochemical tests included in the regulatory framework of GMP. Since September 2017, our laboratory has the certificate of compliance with GMP, and is recognized as a pharmaceutical laboratory to carry out Quality Control activities (physicochemical analysis) of active principles, drugs and raw materials in general; related to both marketed drugs and investigational drugs.

IQS has a total of 6 laboratories: chromatography, spectroscopy, photochemistry, electrochemistry, metal analysis, and thermal analysis that conduct quality control activities to support the industrial sector (pharmaceutical, veterinary, active ingredients, biotechnological, etc.).

GMP ACCREDITATION

IQS has the certificate of compliance with Good Manufacturing Practices, established in Directive 2003/94 / CE, Directive 91/412 / CE, and issued by the Spanish Agency for Medicines and Health Products.

FACILITIES

Metal Analysis Laboratory

Thermal Analysis Laboratory

Chromatography Laboratory

Spectroscopy Laboratory

Photochemistry Laboratory

Electrochemical Laboratory

RESEARCH GROUP:

QuAN

Química Analítica

School of Engineering

Analytical Chemistry Group

QuAN's activity is structured around the different analytical, spectrometric, chromatographic, electrochemical and optical techniques, both in their application and in their development.

GQF

Grup de Química Farmacèutica

School of Engineering

Pharmaceutical Chemistry Group

The research focuses on two main areas: New Drugs in Biomedicine and Health Sciences and Flow Chemistry Processes.

LINKED NEWS

News

Analysis of nitrosamines, nitrites, and nitrates in drugs

08/01/2021
In July 2018, public health authorities became aware of the presence of the N-nitrosodimethylamine (NDMA) impurity in Valsartan batches for the first time. In the following months, other nitrosamines in drugs were detected from the same family (sartans), such as Ibersartan or Losartan, and in other drugs such as pioglitazone, ranitidine, and metformin.
READ FULL NEW
REQUEST
A QUOTE

CONTACT US